LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Mendoza, Luis Alfonso"
  2. AU="Shadyro, Oleg I"
  3. AU="Duce, James A"
  4. AU="Jiménez‐Yuste, Victor"
  5. AU=Jang Jinah
  6. AU="Ullman, Natalie L"
  7. AU="Ding, Xiao-Qiang"
  8. AU="Goyal, Madhav"
  9. AU="Schwarz, E Bimla"
  10. AU="Yamamoto, Naoyuki"
  11. AU="Mansi, Ruaa Abdullah"
  12. AU="Feng, Ruifang"
  13. AU="Rzaigui, Mohamed"
  14. AU="Kuznetsova, Iren"
  15. AU="Töreki, Josefin"
  16. AU="Simon Hatcher" AU="Simon Hatcher"
  17. AU="Gui, Wenwu"
  18. AU="Komdeur, Annemarijn"
  19. AU="Stange, E. F."
  20. AU="McKenzie, Jodi A"
  21. AU="Chung, Mei"
  22. AU="Cezmi A Akdis"
  23. AU="Schlechter, Chelsey R"
  24. AU=Hedayati Manouchehr Ahmadi AU=Hedayati Manouchehr Ahmadi
  25. AU="Gould, Sven B"
  26. AU="Ko, Kyung Dae"
  27. AU="Elaheh Mahmoodi-Khaledi"
  28. AU=Jenkins Kathy J
  29. AU="Joseph Burgess"
  30. AU="Barbosa da Costa, Alana Vitor"
  31. AU="François Lebargy"
  32. AU=Serag Eman AU=Serag Eman
  33. AU="Yang, Guichun"
  34. AU="Amory, Jonathan R"
  35. AU="Reformat, Marek"

Suchergebnis

Treffer 1 - 4 von insgesamt 4

Suchoptionen

  1. Artikel ; Online: Successful recovery of COVID-19 pneumonia in a patient from Colombia after receiving chloroquine and clarithromycin.

    Millán-Oñate, José / Millan, William / Mendoza, Luis Alfonso / Sánchez, Carlos Guillermo / Fernandez-Suarez, Hugo / Bonilla-Aldana, D Katterine / Rodríguez-Morales, Alfonso J

    Annals of clinical microbiology and antimicrobials

    2020  Band 19, Heft 1, Seite(n) 16

    Abstract: Background: COVID-19 pandemics is a challenge for public health and infectious diseases clinicians, especially for the therapeutical approach that is not yet adequately defined. Amid this situation, investigational agents are being used, including ... ...

    Abstract Background: COVID-19 pandemics is a challenge for public health and infectious diseases clinicians, especially for the therapeutical approach that is not yet adequately defined. Amid this situation, investigational agents are being used, including chloroquine. We report here the clinical features and therapeutic course of the first reported patient with confirmed COVID-19 pneumonia that recovered in Colombia, after the use of chloroquine and clarithromycin.
    Case presentation: A 34-year-old male, returning from Spain, presented with complaints of fever, and cough, and class-II obesity, being hospitalized. The respiratory viruses and bacteria tested by FilmArray
    Conclusions: Our patient improved significantly. This and other COVID-19 cases are urgently demanding results from clinical trials that support evidence-based therapeutical approaches to this pandemic and the clinical management of patients, especially those at critical care.
    Mesh-Begriff(e) Adult ; Betacoronavirus ; Chloroquine/therapeutic use ; Clarithromycin/therapeutic use ; Colombia ; Coronavirus Infections/diagnosis ; Coronavirus Infections/drug therapy ; Humans ; Male ; Pandemics ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/drug therapy
    Chemische Substanzen Chloroquine (886U3H6UFF) ; Clarithromycin (H1250JIK0A)
    Schlagwörter covid19
    Sprache Englisch
    Erscheinungsdatum 2020-04-24
    Erscheinungsland England
    Dokumenttyp Case Reports ; Journal Article
    ZDB-ID 2097873-X
    ISSN 1476-0711 ; 1476-0711
    ISSN (online) 1476-0711
    ISSN 1476-0711
    DOI 10.1186/s12941-020-00358-y
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Successful recovery of COVID-19 pneumonia in a patient from Colombia after receiving chloroquine and clarithromycin

    Millán-Oñate, José / Millan, William / Mendoza, Luis Alfonso / Sánchez, Carlos Guillermo / Fernandez-Suarez, Hugo / Bonilla-Aldana, D. Katterine / Rodríguez-Morales, Alfonso J.

    Annals of Clinical Microbiology and Antimicrobials

    2020  Band 19, Heft 1

    Schlagwörter Microbiology (medical) ; Infectious Diseases ; General Medicine ; covid19
    Sprache Englisch
    Verlag Springer Science and Business Media LLC
    Erscheinungsland us
    Dokumenttyp Artikel ; Online
    ZDB-ID 2097873-X
    ISSN 1476-0711
    ISSN 1476-0711
    DOI 10.1186/s12941-020-00358-y
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

  3. Artikel: Successful recovery of COVID-19 pneumonia in a patient from Colombia after receiving chloroquine and clarithromycin

    Millán-Oñate, José / Millan, William / Mendoza, Luis Alfonso / Sánchez, Carlos Guillermo / Fernandez-Suarez, Hugo / Bonilla-Aldana, D Katterine / Rodríguez-Morales, Alfonso J

    Ann Clin Microbiol Antimicrob

    Abstract: BACKGROUND: COVID-19 pandemics is a challenge for public health and infectious diseases clinicians, especially for the therapeutical approach that is not yet adequately defined. Amid this situation, investigational agents are being used, including ... ...

    Abstract BACKGROUND: COVID-19 pandemics is a challenge for public health and infectious diseases clinicians, especially for the therapeutical approach that is not yet adequately defined. Amid this situation, investigational agents are being used, including chloroquine. We report here the clinical features and therapeutic course of the first reported patient with confirmed COVID-19 pneumonia that recovered in Colombia, after the use of chloroquine and clarithromycin. CASE PRESENTATION: A 34-year-old male, returning from Spain, presented with complaints of fever, and cough, and class-II obesity, being hospitalized. The respiratory viruses and bacteria tested by FilmArray® PCR were negative. Two days later, clarithromycin was started because the patient was suspected as community-acquired pneumonia. At the third day, the rRT-PCR confirmed the SARS-CoV-2 infection. A day later, chloroquine was started because of that. His chest computed tomography was performed and showed bilateral multifocal ground-glass opacities with consolidation, which suggested viral pneumonia as a differential diagnosis. Progressively his clinical condition improved and at day 9, patient rRT-PCR for SARS-CoV-2 became negative. The patient was discharged and isolated at home per 14 days. CONCLUSIONS: Our patient improved significantly. This and other COVID-19 cases are urgently demanding results from clinical trials that support evidence-based therapeutical approaches to this pandemic and the clinical management of patients, especially those at critical care.
    Schlagwörter covid19
    Verlag WHO
    Dokumenttyp Artikel
    Anmerkung WHO #Covidence: #116464
    Datenquelle COVID19

    Kategorien

  4. Artikel ; Online: Successful recovery of COVID-19 pneumonia in a patient from Colombia after receiving chloroquine and clarithromycin

    Millán-Oñate, José / Millan, William / Mendoza, Luis Alfonso / Sánchez, Carlos Guillermo / Fernandez-Suarez, Hugo / Bonilla-Aldana, D. Katterine / Rodríguez-Morales, Alfonso J.

    Annals of clinical microbiology and antimicrobials, 19(1):16

    2020  

    Abstract: BACKGROUND: COVID-19 pandemics is a challenge for public health and infectious diseases clinicians, especially for the therapeutical approach that is not yet adequately defined. Amid this situation, investigational agents are being used, including ... ...

    Abstract BACKGROUND: COVID-19 pandemics is a challenge for public health and infectious diseases clinicians, especially for the therapeutical approach that is not yet adequately defined. Amid this situation, investigational agents are being used, including chloroquine. We report here the clinical features and therapeutic course of the first reported patient with confirmed COVID-19 pneumonia that recovered in Colombia, after the use of chloroquine and clarithromycin. CASE REPRESENTATION: A 34-year-old male, returning from Spain, presented with complaints of fever, and cough, and class-II obesity, being hospitalized. The respiratory viruses and bacteria tested by FilmArray® PCR were negative. Two days later, clarithromycin was started because the patient was suspected as community-acquired pneumonia. At the third day, the rRT-PCR confirmed the SARS-CoV-2 infection. A day later, chloroquine was started because of that. His chest computed tomography was performed and showed bilateral multifocal ground-glass opacities with consolidation, which suggested viral pneumonia as a differential diagnosis. Progressively his clinical condition improved and at day 9, patient rRT-PCR for SARS-CoV-2 became negative. The patient was discharged and isolated at home per 14 days. CONCLUSIONS: Our patient improved significantly. This and other COVID-19 cases are urgently demanding results from clinical trials that support evidence-based therapeutical approaches to this pandemic and the clinical management of patients, especially those at critical care.
    Schlagwörter COVID-19 ; Chloroquine ; Coronavirus Disease 2019 ; Latin America ; Severe Acute Respiratory Syndrome Coronavirus 2 ; Colombia ; SARS-CoV-2 ; covid19
    Sprache Englisch
    Erscheinungsland de
    Dokumenttyp Artikel ; Online
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang